BIND THERAPEUTICS INC Instrumento Inactivo
Acciones BIND Therapeutics Inc Nasdaq
Acciones
US05548N1072
Biotecnología e investigación médica
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
Stephen Zale
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/11/06 |
Tom Baker
IRC | Investor Relations Contact | - | - |
Neil Bander
PRN | Corporate Officer/Principal | - | - |
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
| Corporate Officer/Principal | - | 24/07/16 |
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| -2,31 % | 103 mil M | |
| +0,56 % | 95,28 mil M | |
| +1,69 % | 22,15 mil M | |
| -17,37 % | 21,02 mil M | |
| -9,30 % | 18,15 mil M | |
| -41,01 % | 16,74 mil M | |
| -14,85 % | 16,05 mil M | |
| +3,21 % | 13,68 mil M | |
| +33,54 % | 12,17 mil M |
